$INCY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INCYTE CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INCYTE CORP. Get notifications about new insider transactions in INCYTE CORP for free.
Page: < prev 1 ... 9 10 11 12 13 14 15 16 17 ... 21 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 2014 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Sell | S | 64.74 | 40,000 | 2,589,600 | 8,500 | 48.5 K to 8.5 K (-82.47 %) |
| Feb 18 2014 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Buy | M | 8.99 | 5,036 | 45,274 | 48,500 | 43.5 K to 48.5 K (+11.59 %) |
| Feb 18 2014 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Buy | M | 8.99 | 34,964 | 314,326 | 43,464 | 8.5 K to 43.5 K (+411.34 %) |
| Feb 18 2014 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Sell | S | 66.12 | 202,999 | 13,422,294 | 8,500 | 211.5 K to 8.5 K (-95.98 %) |
| Feb 18 2014 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Buy | M | 17.79 | 66,000 | 1,174,140 | 211,499 | 145.5 K to 211.5 K (+45.36 %) |
| Feb 18 2014 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Buy | M | 11.98 | 90,335 | 1,082,213 | 145,499 | 55.2 K to 145.5 K (+163.76 %) |
| Feb 18 2014 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Buy | M | 18.32 | 16,000 | 293,120 | 55,164 | 39.2 K to 55.2 K (+40.85 %) |
| Feb 18 2014 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Buy | M | 14.72 | 13,000 | 191,360 | 39,164 | 26.2 K to 39.2 K (+49.69 %) |
| Feb 18 2014 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Buy | M | 11.98 | 9,665 | 115,787 | 26,164 | 16.5 K to 26.2 K (+58.58 %) |
| Feb 18 2014 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Buy | M | 8.99 | 7,999 | 71,911 | 16,499 | 8.5 K to 16.5 K (+94.11 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 13.34 | 417 | 5,563 | 0 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 13.34 | 14,583 | 194,537 | 0 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 9.41 | 24,787 | 233,246 | 0 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 11.98 | 1,945 | 23,301 | 0 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 11.98 | 9,138 | 109,473 | 0 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 9.41 | 12,300 | 115,743 | 0 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 11.98 | 25,862 | 309,827 | 0 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 9.41 | 47,913 | 450,861 | 24,787 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 3.11 | 61,096 | 190,009 | 0 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 11.98 | 33,055 | 395,999 | 0 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 66.13 | 39,787 | 2,631,114 | 4,301 | 44.1 K to 4.3 K (-90.24 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 13.34 | 417 | 5,563 | 44,088 | 43.7 K to 44.1 K (+0.95 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 13.34 | 14,583 | 194,537 | 43,671 | 29.1 K to 43.7 K (+50.13 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 9.41 | 24,787 | 233,246 | 29,088 | 4.3 K to 29.1 K (+576.31 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 66.38 | 191,309 | 12,699,091 | 4,301 | 195.6 K to 4.3 K (-97.80 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 11.98 | 1,945 | 23,301 | 195,610 | 193.7 K to 195.6 K (+1.00 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 11.98 | 9,138 | 109,473 | 193,665 | 184.5 K to 193.7 K (+4.95 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 9.41 | 12,300 | 115,743 | 184,527 | 172.2 K to 184.5 K (+7.14 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 11.98 | 25,862 | 309,827 | 172,227 | 146.4 K to 172.2 K (+17.67 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 9.41 | 47,913 | 450,861 | 146,365 | 98.5 K to 146.4 K (+48.67 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 3.11 | 61,096 | 190,009 | 98,452 | 37.4 K to 98.5 K (+163.55 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 11.98 | 33,055 | 395,999 | 37,356 | 4.3 K to 37.4 K (+768.54 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 118,481 | 1,969,154 | 163,471 | |
| Feb 18 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 6,517 | 108,313 | 11,531 | |
| Feb 18 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 18.32 | 33,333 | 610,661 | 61,209 | |
| Feb 18 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Sell | S | 66.49 | 158,331 | 10,527,428 | 0 | 158.3 K to 0 (-100.00 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 118,481 | 1,969,154 | 158,331 | 39.9 K to 158.3 K (+297.32 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 6,517 | 108,313 | 39,850 | 33.3 K to 39.9 K (+19.55 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 18.32 | 33,333 | 610,661 | 33,333 | 0 to 33.3 K |
| Jan 23 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | A | 64.55 | 34,342 | 2,216,776 | 34,342 | |
| Jan 23 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | A | 64.55 | 982 | 63,388 | 982 | |
| Jan 23 2014 | INCY | INCYTE CORP | Chardonnet Laurent | Option Exercise | A | 64.55 | 6,943 | 448,171 | 6,943 | ||
| Jan 23 2014 | INCY | INCYTE CORP | Chardonnet Laurent | Option Exercise | A | 64.55 | 1,143 | 73,781 | 1,143 | ||
| Jan 23 2014 | INCY | INCYTE CORP | Chardonnet Laurent | Grant | A | 0.00 | 1,135 | 0 | 3,193 | 2.1 K to 3.2 K (+55.15 %) | |
| Jan 23 2014 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | A | 64.55 | 23,852 | 1,539,647 | 23,852 | |
| Jan 23 2014 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | A | 64.55 | 977 | 63,065 | 977 | |
| Jan 23 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 64.55 | 34,868 | 2,250,729 | 34,868 | |
| Jan 23 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 64.55 | 997 | 64,356 | 997 | |
| Jan 23 2014 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | A | 64.55 | 24,139 | 1,558,172 | 24,139 | |
| Jan 23 2014 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | A | 64.55 | 690 | 44,540 | 690 | |
| Jan 23 2014 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Option Exercise | A | 64.55 | 23,379 | 1,509,114 | 23,379 | |
| Jan 23 2014 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Option Exercise | A | 64.55 | 1,450 | 93,598 | 1,450 | |
| Jan 23 2014 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | A | 64.55 | 7,500 | 484,125 | 7,500 | |
| Jan 23 2014 | INCY | INCYTE CORP | Hoppenot Herve | Chief Executive Off ... | Option Exercise | A | 64.55 | 119,501 | 7,713,790 | 119,501 | |
| Jan 23 2014 | INCY | INCYTE CORP | Hoppenot Herve | Chief Executive Off ... | Option Exercise | A | 64.55 | 4,647 | 299,964 | 4,647 | |
| Jan 15 2014 | INCY | INCYTE CORP | Hoppenot Herve | President and CEO | Grant | A | 0.00 | 400,000 | 0 | 400,000 | 0 to 400 K |
| Dec 20 2013 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Payment of Exercise | F | 50.11 | 24,350 | 1,220,179 | 417,518 | 441.9 K to 417.5 K (-5.51 %) |
| Dec 19 2013 | INCY | INCYTE CORP | WHITFIELD ROY A | Director | Option Exercise | M | 7.68 | 15,000 | 115,200 | 5,000 | |
| Dec 19 2013 | INCY | INCYTE CORP | WHITFIELD ROY A | Director | Option Exercise | M | 7.26 | 20,000 | 145,200 | 0 | |
| Dec 19 2013 | INCY | INCYTE CORP | WHITFIELD ROY A | Director | Option Exercise | M | 7.02 | 10,000 | 70,200 | 0 | |
| Dec 19 2013 | INCY | INCYTE CORP | WHITFIELD ROY A | Director | Buy | M | 7.68 | 15,000 | 115,200 | 666,082 | 651.1 K to 666.1 K (+2.30 %) |
| Dec 19 2013 | INCY | INCYTE CORP | WHITFIELD ROY A | Director | Buy | M | 7.26 | 20,000 | 145,200 | 651,082 | 631.1 K to 651.1 K (+3.17 %) |
| Dec 19 2013 | INCY | INCYTE CORP | WHITFIELD ROY A | Director | Buy | M | 7.02 | 10,000 | 70,200 | 631,082 | 621.1 K to 631.1 K (+1.61 %) |
| Nov 20 2013 | INCY | INCYTE CORP | WHITFIELD ROY A | Director | Sell | S | 47.37 | 50,000 | 2,368,500 | 621,082 | 671.1 K to 621.1 K (-7.45 %) |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | D | 8.78 | 127,000 | 1,114,425 | 892,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | D | 8.78 | 4,567,000 | 40,075,425 | 31,967,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | D | 8.78 | 1,084,000 | 9,512,100 | 7,587,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | D | 8.78 | 2,459,000 | 21,577,725 | 1,019,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | D | 8.78 | 88,153,000 | 773,542,575 | 36,534,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | D | 8.78 | 20,922,000 | 183,590,550 | 8,671,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 170,000 | 8,798,860 | 6,050,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 6,830,000 | 353,507,140 | 243,450,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 242,000 | 12,525,436 | 5,880,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 9,758,000 | 505,054,564 | 236,620,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 61,000 | 3,157,238 | 5,638,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 2,439,000 | 126,237,762 | 226,862,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 121,000 | 6,262,718 | 5,577,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 4,879,000 | 252,527,282 | 224,423,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 5,456,000 | 282,391,648 | 5,456,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 219,544,000 | 11,363,158,352 | 219,544,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 25,000,000 | 1,293,950,000 | 25,000,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 133,000 | 6,883,814 | 5,674,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 5,367,000 | 277,785,186 | 228,326,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 85,000 | 4,399,430 | 5,541,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 3,415,000 | 176,753,570 | 222,959,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 5,456,000 | 282,391,648 | 5,456,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 219,544,000 | 11,363,158,352 | 219,544,000 | |
| Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 25,000,000 | 1,293,950,000 | 25,000,000 | |
| Sep 12 2013 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Option Exercise | M | 7.09 | 189,105 | 1,340,754 | 0 | |
| Sep 12 2013 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Option Exercise | M | 8.64 | 43,125 | 372,600 | 0 | |
| Sep 12 2013 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Option Exercise | M | 8.64 | 144,559 | 1,248,990 | 0 | |
| Sep 12 2013 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Sell | S | 37.32 | 376,789 | 14,061,765 | 391,868 | 768.7 K to 391.9 K (-49.02 %) |
| Sep 12 2013 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | M | 7.09 | 189,105 | 1,340,754 | 768,657 | 579.6 K to 768.7 K (+32.63 %) |
| Sep 12 2013 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | M | 8.64 | 43,125 | 372,600 | 579,552 | 536.4 K to 579.6 K (+8.04 %) |
| Sep 12 2013 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | M | 8.64 | 144,559 | 1,248,990 | 536,427 | 391.9 K to 536.4 K (+36.89 %) |
| Sep 09 2013 | INCY | INCYTE CORP | Chardonnet Laurent | Option Exercise | M | 8.73 | 5,733 | 50,049 | 0 | ||
| Sep 09 2013 | INCY | INCYTE CORP | Chardonnet Laurent | Option Exercise | M | 7.09 | 4,300 | 30,487 | 0 | ||
| Sep 09 2013 | INCY | INCYTE CORP | Chardonnet Laurent | Option Exercise | M | 8.73 | 31,767 | 277,326 | 0 | ||
| Sep 09 2013 | INCY | INCYTE CORP | Chardonnet Laurent | Sell | S | 37.90 | 36,067 | 1,366,939 | 2,023 | 38.1 K to 2 K (-94.69 %) | |
| Sep 09 2013 | INCY | INCYTE CORP | Chardonnet Laurent | Sell | S | 34.90 | 8,767 | 305,968 | 38,090 | 46.9 K to 38.1 K (-18.71 %) | |
| Sep 09 2013 | INCY | INCYTE CORP | Chardonnet Laurent | Buy | M | 8.73 | 5,733 | 50,049 | 46,857 | 41.1 K to 46.9 K (+13.94 %) | |
| Sep 09 2013 | INCY | INCYTE CORP | Chardonnet Laurent | Buy | M | 7.09 | 4,300 | 30,487 | 41,124 | 36.8 K to 41.1 K (+11.68 %) | |
| Sep 09 2013 | INCY | INCYTE CORP | Chardonnet Laurent | Buy | M | 8.73 | 31,767 | 277,326 | 36,824 | 5.1 K to 36.8 K (+628.18 %) | |
| Sep 09 2013 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | M | 7.09 | 94,444 | 669,608 | 0 | |
| Sep 09 2013 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Sell | S | 35.06 | 94,444 | 3,311,207 | 18,061 | 112.5 K to 18.1 K (-83.95 %) |
| Sep 09 2013 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Buy | M | 7.09 | 94,444 | 669,608 | 112,505 | 18.1 K to 112.5 K (+522.92 %) |
| Sep 09 2013 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 17.79 | 35,413 | 629,997 | 33,006 | |
| Sep 09 2013 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 14.00 | 4,167 | 58,338 | 2,778 | |
| Sep 09 2013 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 14.72 | 6,666 | 98,124 | 4,445 | |
| Sep 09 2013 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 16.66 | 9,732 | 162,135 | 3,245 | |
| Sep 09 2013 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Sell | S | 35.17 | 55,978 | 1,968,746 | 899 | 56.9 K to 899 (-98.42 %) |
| Sep 09 2013 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 17.79 | 35,413 | 629,997 | 56,877 | 21.5 K to 56.9 K (+164.99 %) |
| Sep 09 2013 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 14.00 | 4,167 | 58,338 | 21,464 | 17.3 K to 21.5 K (+24.09 %) |
| Sep 09 2013 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 14.72 | 6,666 | 98,124 | 17,297 | 10.6 K to 17.3 K (+62.70 %) |
| Sep 09 2013 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 16.66 | 9,732 | 162,135 | 10,631 | 899 to 10.6 K (+1,082.54 %) |
| Sep 09 2013 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Option Exercise | M | 7.09 | 5,556 | 39,392 | 0 | |
| Sep 09 2013 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Option Exercise | M | 7.09 | 94,444 | 669,608 | 0 | |
| Sep 09 2013 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Sell | S | 35.16 | 100,000 | 3,516,000 | 8,500 | 108.5 K to 8.5 K (-92.17 %) |
| Sep 09 2013 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Buy | M | 7.09 | 5,556 | 39,392 | 108,500 | 102.9 K to 108.5 K (+5.40 %) |
| Sep 09 2013 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Buy | M | 7.09 | 94,444 | 669,608 | 102,944 | 8.5 K to 102.9 K (+1,111.11 %) |
| Sep 09 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 11.98 | 25,000 | 299,500 | 862 | |
| Sep 09 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 35.28 | 25,000 | 882,000 | 0 | 25 K to 0 (-100.00 %) |
| Sep 09 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 11.98 | 25,000 | 299,500 | 25,000 | 0 to 25 K |
| Aug 20 2013 | INCY | INCYTE CORP | WHITFIELD ROY A | Director | Sell | S | 26.70 | 50,000 | 1,335,000 | 671,082 | 721.1 K to 671.1 K (-6.93 %) |
| May 31 2013 | INCY | INCYTE CORP | BROOKE PAUL A | Director | Option Exercise | A | 22.74 | 20,000 | 454,800 | 20,000 | |
| Jun 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | M | 4.44 | 10,000 | 44,400 | 10,000 | |
| Jun 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | M | 4.44 | 10,000 | 44,400 | 10,000 | |
| Jun 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | M | 4.44 | 10,000 | 44,400 | 10,000 | |
| Jun 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 4.44 | 10,000 | 44,400 | 380,839 | 370.8 K to 380.8 K (+2.70 %) |
| Jun 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 4.44 | 10,000 | 44,400 | 12,455,783 | 12.4 M to 12.5 M (+0.08 %) |
| Jun 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 4.44 | 10,000 | 44,400 | 2,048,937 | 2 M to 2 M (+0.49 %) |
| May 31 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | A | 22.74 | 20,000 | 454,800 | 20,000 | |
| May 31 2013 | INCY | INCYTE CORP | DE SCHUTTER RICHARD U | Director | Option Exercise | A | 22.74 | 20,000 | 454,800 | 20,000 | |
| May 31 2013 | INCY | INCYTE CORP | WHITFIELD ROY A | Director | Option Exercise | A | 22.74 | 20,000 | 454,800 | 20,000 | |
| May 31 2013 | INCY | INCYTE CORP | DIXON WENDY L | Director | Option Exercise | A | 22.74 | 20,000 | 454,800 | 20,000 | |
| May 31 2013 | INCY | INCYTE CORP | ARIKO BARRY A | Director | Option Exercise | A | 22.74 | 20,000 | 454,800 | 20,000 | |
| May 21 2013 | INCY | INCYTE CORP | WHITFIELD ROY A | Director | Sell | S | 23.08 | 40,000 | 923,200 | 721,082 | 761.1 K to 721.1 K (-5.26 %) |
| May 15 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 7.09 | 4,301 | 30,494 | 0 | |
| May 15 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 7.09 | 55,699 | 394,906 | 0 | |
| May 15 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 22.30 | 55,699 | 1,242,088 | 4,301 | 60 K to 4.3 K (-92.83 %) |
| May 15 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 7.09 | 4,301 | 30,494 | 60,000 | 55.7 K to 60 K (+7.72 %) |
| May 15 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 7.09 | 55,699 | 394,906 | 55,699 | 0 to 55.7 K |
| May 07 2013 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Option Exercise | M | 9.41 | 13,513 | 127,157 | 0 | |
| May 07 2013 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Option Exercise | M | 13.34 | 834 | 11,126 | 0 | |
| May 07 2013 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Option Exercise | M | 14.72 | 1,006 | 14,808 | 8,805 | |
| May 07 2013 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Option Exercise | M | 11.98 | 8,347 | 99,997 | 0 | |
| May 07 2013 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | M | 9.41 | 13,513 | 127,157 | 391,868 | 378.4 K to 391.9 K (+3.57 %) |
| May 07 2013 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | M | 13.34 | 834 | 11,126 | 378,355 | 377.5 K to 378.4 K (+0.22 %) |
| May 07 2013 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | M | 14.72 | 1,006 | 14,808 | 377,521 | 376.5 K to 377.5 K (+0.27 %) |
| May 07 2013 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | M | 11.98 | 8,347 | 99,997 | 376,515 | 368.2 K to 376.5 K (+2.27 %) |